Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

14 treatments under study, led by Future Life Planning Tool Future

Research Leaders

18 sponsors active, led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
Phase 2 (1)

Trial Status

Completed5
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Future Life Planning Tool Future1
  • Ulipristal Acetate1
  • Narrative Videos Narratives1
  • Epidemiological Risk Scenario Risk1
  • Levonorgestrel Ius1

Active Sponsors

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • William and Flora Hewlett Foundation1
  • Family and Youth Services Bureau1
  • Network for Engineering and Economics Research and Management1
  • ETR Associates1

Top Investigators

Related Conditions

  • Contraceptive Behavior1
  • Sexually Transmitted Diseases1
  • Sexually Transmitted Infections1
  • Military Personnel1
  • Pregnancy Accident1

Activity Timeline